Ultragenyx Pharmaceutical (NASDAQ:RARE) SVP Thomas Richard Kassberg unloaded 20,000 shares of the stock on the open market in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $53.91, for a total transaction of $1,078,200.00. Following the sale, the senior vice president now directly owns 105,804 shares in the company, valued at approximately $5,703,894. The sale was disclosed in … Continue reading Investors Are Watching : Ultragenyx Pharmaceutical (NASDAQ:RARE), Bankrate, Inc. (NYSE:RATE), American Shared Hospital Services (NYSEMKT:AMS), Calamos Asset (NASDAQ:CLMS), Canadian National Railway (NYSE:CNI)